TY - JOUR
T1 - Integrated personalized diabetes management goes Europe
T2 - A multi-disciplinary approach to innovating type 2 diabetes care in Europe
AU - Jones, Allan
AU - Bardram, Jakob Eyvind
AU - Bækgaard, Per
AU - Cramer-Petersen, Claus Lundgaard
AU - Skinner, Timothy
AU - Vrangbæk, Karsten
AU - Starr, Laila
AU - Nørgaard, Kirsten
AU - Lind, Nanna
AU - Bechmann Christensen, Merete
AU - Glümer, Charlotte
AU - Wang-Sattler, Rui
AU - Laxy, Michael
AU - Brander, Erik
AU - Heinemann, Lutz
AU - Heise, Tim
AU - Schliess, Freimut
AU - Ladewig, Katharina
AU - Kownatka, Dagmar
PY - 2021
Y1 - 2021
N2 - Type 2 diabetes mellitus represents a multi-dimensional challenge for European and global societies alike. Building on an iterative six-step disease management process that leverages feedback loops and utilizes commodity digital tools, the PDM-ProValue study program demonstrated that integrated personalized diabetes management, or iPDM, can improve the standard of care for persons living with diabetes in a sustainable way. The novel “iPDM Goes Europe” consortium strives to advance iPDM adoption by (1) implementing the concept in a value-based healthcare setting for the treatment of persons living with type 2 diabetes, (2) providing tools to assess the patient's physical and mental health status, and (3) exploring new avenues to take advantage of emerging big data resources.
AB - Type 2 diabetes mellitus represents a multi-dimensional challenge for European and global societies alike. Building on an iterative six-step disease management process that leverages feedback loops and utilizes commodity digital tools, the PDM-ProValue study program demonstrated that integrated personalized diabetes management, or iPDM, can improve the standard of care for persons living with diabetes in a sustainable way. The novel “iPDM Goes Europe” consortium strives to advance iPDM adoption by (1) implementing the concept in a value-based healthcare setting for the treatment of persons living with type 2 diabetes, (2) providing tools to assess the patient's physical and mental health status, and (3) exploring new avenues to take advantage of emerging big data resources.
KW - Artificial intelligence
KW - Delivery of health care, integrated
KW - Diabetes mellitus, type 2
KW - Patient reported outcome measures
KW - Value-based health insurance
U2 - 10.1016/j.pcd.2020.10.008
DO - 10.1016/j.pcd.2020.10.008
M3 - Review
C2 - 33184011
AN - SCOPUS:85095835886
SN - 1751-9918
VL - 15
SP - 360
EP - 364
JO - Primary Care Diabetes
JF - Primary Care Diabetes
IS - 2
ER -
